237 related articles for article (PubMed ID: 22461672)
1. Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution.
Pfaller MA; Espinel-Ingroff A; Canton E; Castanheira M; Cuenca-Estrella M; Diekema DJ; Fothergill A; Fuller J; Ghannoum M; Jones RN; Lockhart SR; Martin-Mazuelos E; Melhem MS; Ostrosky-Zeichner L; Pappas P; Pelaez T; Peman J; Rex J; Szeszs MW
J Clin Microbiol; 2012 Jun; 50(6):2040-6. PubMed ID: 22461672
[TBL] [Abstract][Full Text] [Related]
2. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
Karabıçak N; Alem N
Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
[TBL] [Abstract][Full Text] [Related]
3. Comparison of three statistical methods for establishing tentative wild-type population and epidemiological cutoff values for echinocandins, amphotericin B, flucytosine, and six Candida species as determined by the colorimetric Sensititre YeastOne method.
Cantón E; Pemán J; Hervás D; Iñiguez C; Navarro D; Echeverría J; Martínez-Alarcón J; Fontanals D; Gomila-Sard B; Buendía B; Torroba L; Ayats J; Bratos A; Sánchez-Reus F; Fernández-Natal I;
J Clin Microbiol; 2012 Dec; 50(12):3921-6. PubMed ID: 23015676
[TBL] [Abstract][Full Text] [Related]
4. Wild-type MIC distributions and epidemiological cutoff values for posaconazole and voriconazole and Candida spp. as determined by 24-hour CLSI broth microdilution.
Pfaller MA; Boyken L; Hollis RJ; Kroeger J; Messer SA; Tendolkar S; Diekema DJ
J Clin Microbiol; 2011 Feb; 49(2):630-7. PubMed ID: 21159940
[TBL] [Abstract][Full Text] [Related]
5. Multicenter study of anidulafungin and micafungin MIC distributions and epidemiological cutoff values for eight Candida species and the CLSI M27-A3 broth microdilution method.
Pfaller MA; Espinel-Ingroff A; Bustamante B; Canton E; Diekema DJ; Fothergill A; Fuller J; Gonzalez GM; Guarro J; Lass-Flörl C; Lockhart SR; Martin-Mazuelos E; Meis JF; Ostrosky-Zeichner L; Pelaez T; St-Germain G; Turnidge J
Antimicrob Agents Chemother; 2014; 58(2):916-22. PubMed ID: 24277027
[TBL] [Abstract][Full Text] [Related]
6. Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion Method.
Espinel-Ingroff A; Arendrup M; Cantón E; Cordoba S; Dannaoui E; García-Rodríguez J; Gonzalez GM; Govender NP; Martin-Mazuelos E; Lackner M; Lass-Flörl C; Linares Sicilia MJ; Rodriguez-Iglesias MA; Pelaez T; Shields RK; Garcia-Effron G; Guinea J; Sanguinetti M; Turnidge J
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799206
[TBL] [Abstract][Full Text] [Related]
7. Wild-type MIC distributions and epidemiological cutoff values for the echinocandins and Candida spp.
Pfaller MA; Boyken L; Hollis RJ; Kroeger J; Messer SA; Tendolkar S; Jones RN; Turnidge J; Diekema DJ
J Clin Microbiol; 2010 Jan; 48(1):52-6. PubMed ID: 19923478
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the Sensititre YeastOne colorimetric antifungal panel with CLSI microdilution for antifungal susceptibility testing of the echinocandins against Candida spp., using new clinical breakpoints and epidemiological cutoff values.
Pfaller MA; Chaturvedi V; Diekema DJ; Ghannoum MA; Holliday NM; Killian SB; Knapp CC; Messer SA; Miskou A; Ramani R
Diagn Microbiol Infect Dis; 2012 Aug; 73(4):365-8. PubMed ID: 22726528
[TBL] [Abstract][Full Text] [Related]
9. Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance in
Espinel-Ingroff A; Turnidge J; Alastruey-Izquierdo A; Botterel F; Canton E; Castro C; Chen YC; Chen Y; Chryssanthou E; Dannaoui E; Garcia-Effron G; Gonzalez GM; Govender NP; Guinea J; Kidd S; Lackner M; Lass-Flörl C; Linares-Sicilia MJ; López-Soria L; Magobo R; Pelaez T; Quindós G; Rodriguez-Iglesia MA; Ruiz MA; Sánchez-Reus F; Sanguinetti M; Shields R; Szweda P; Tortorano A; Wengenack NL; Bramati S; Cavanna C; DeLuca C; Gelmi M; Grancini A; Lombardi G; Meletiadis J; Negri CE; Passera M; Peman J; Prigitano A; Sala E; Tejada M
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30323038
[TBL] [Abstract][Full Text] [Related]
10. Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?
Espinel-Ingroff A; Arendrup MC; Pfaller MA; Bonfietti LX; Bustamante B; Canton E; Chryssanthou E; Cuenca-Estrella M; Dannaoui E; Fothergill A; Fuller J; Gaustad P; Gonzalez GM; Guarro J; Lass-Flörl C; Lockhart SR; Meis JF; Moore CB; Ostrosky-Zeichner L; Pelaez T; Pukinskas SR; St-Germain G; Szeszs MW; Turnidge J
Antimicrob Agents Chemother; 2013 Dec; 57(12):5836-42. PubMed ID: 24018263
[TBL] [Abstract][Full Text] [Related]
11. Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates.
Pfaller MA; Messer SA; Bolmström A; Odds FC; Rex JH
J Clin Microbiol; 1996 Jul; 34(7):1691-3. PubMed ID: 8784571
[TBL] [Abstract][Full Text] [Related]
12. Multilaboratory study of epidemiological cutoff values for detection of resistance in eight Candida species to fluconazole, posaconazole, and voriconazole.
Espinel-Ingroff A; Pfaller MA; Bustamante B; Canton E; Fothergill A; Fuller J; Gonzalez GM; Lass-Flörl C; Lockhart SR; Martin-Mazuelos E; Meis JF; Melhem MS; Ostrosky-Zeichner L; Pelaez T; Szeszs MW; St-Germain G; Bonfietti LX; Guarro J; Turnidge J
Antimicrob Agents Chemother; 2014; 58(4):2006-12. PubMed ID: 24419346
[TBL] [Abstract][Full Text] [Related]
13. Triazole and echinocandin MIC distributions with epidemiological cutoff values for differentiation of wild-type strains from non-wild-type strains of six uncommon species of Candida.
Pfaller MA; Castanheira M; Diekema DJ; Messer SA; Jones RN
J Clin Microbiol; 2011 Nov; 49(11):3800-4. PubMed ID: 21900519
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of the ASTY colorimetric microdilution panel for antifungal susceptibility testing.
Pfaller MA; Arikan S; Lozano-Chiu M; Chen Y; Coffman S; Messer SA; Rennie R; Sand C; Heffner T; Rex JH; Wang J; Yamane N
J Clin Microbiol; 1998 Sep; 36(9):2609-12. PubMed ID: 9705401
[TBL] [Abstract][Full Text] [Related]
15. Etest ECVs/ECOFFs for Detection of Resistance in Prevalent and Three Nonprevalent
Espinel-Ingroff A; Sasso M; Turnidge J; Arendrup M; Botterel F; Bourgeois N; Bouteille B; Canton E; Cassaing S; Dannaoui E; Dehais M; Delhaes L; Dupont D; Fekkar A; Fuller J; Garcia-Effron G; Garcia J; Gonzalez GM; Govender NP; Guegan H; Guinea J; Houzé S; Lass-Flörl C; Pelaez T; Forastiero A; Lackner M; Magobo R
Antimicrob Agents Chemother; 2021 Oct; 65(11):e0109321. PubMed ID: 34370582
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the Vitek 2 yeast susceptibility system with CLSI microdilution for antifungal susceptibility testing of fluconazole and voriconazole against Candida spp., using new clinical breakpoints and epidemiological cutoff values.
Pfaller MA; Diekema DJ; Procop GW; Rinaldi MG
Diagn Microbiol Infect Dis; 2013 Sep; 77(1):37-40. PubMed ID: 23870164
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole for six Candida species as determined by the colorimetric Sensititre YeastOne method.
Cantón E; Pemán J; Iñiguez C; Hervás D; Lopez-Hontangas JL; Pina-Vaz C; Camarena JJ; Campos-Herrero I; García-García I; García-Tapia AM; Guna R; Merino P; Pérez del Molino L; Rubio C; Suárez A;
J Clin Microbiol; 2013 Aug; 51(8):2691-5. PubMed ID: 23761155
[TBL] [Abstract][Full Text] [Related]
18. Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosine.
Espinel-Ingroff A; Chowdhary A; Cuenca-Estrella M; Fothergill A; Fuller J; Hagen F; Govender N; Guarro J; Johnson E; Lass-Flörl C; Lockhart SR; Martins MA; Meis JF; Melhem MS; Ostrosky-Zeichner L; Pelaez T; Pfaller MA; Schell WA; Trilles L; Kidd S; Turnidge J
Antimicrob Agents Chemother; 2012 Jun; 56(6):3107-13. PubMed ID: 22391546
[TBL] [Abstract][Full Text] [Related]
19. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
Takakura S; Fujihara N; Saito T; Kudo T; Iinuma Y; Ichiyama S
J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039
[TBL] [Abstract][Full Text] [Related]
20. Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.
Warnock DW; Johnson EM; Rogers TR
J Antimicrob Chemother; 1998 Sep; 42(3):321-31. PubMed ID: 9786472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
